Synthetic Biology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Synthetic Biology Market: By Technology (Enabled Products(Pharmaceuticals, Chemicals, Biofuels), Enabling Products(DNA Synthesis, Oligonucleotide Synthesis), Core Products(Synthetic DNA, XNA, Chassis Organism)), By Application (Chemicals, Pharmaceuticals, Biopharmaceuticals, Agriculture, Others), and Geography

 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global synthetic biology market size is estimated to reach USD 9.32 billion at a CAGR of 26.5% from 2021 to 2027. Synthetic biology is a new interdisciplinary area of medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within the both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for development of artificial biological systems for research engineering and medical applications. The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market. For instance, in March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver.

Synthetic Biology Market

MARKET SUMMARY
-
26.5 %
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 26.5%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Synthetic Biology Market Report

  • The report on global synthetic biology market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, form type and geography.
  • synthetic biology market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Major Key Players
  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • GEN9 Inc.
  • Amyris Biotechnologies
  • Merck KGaA
Drivers And Restrains

Synthetic Biology Market

Synthetic biology market is driven by the rapid increase in R&D investments in synthetic biology and adaptation of genetically engineered products and DNA sequencing for the treatment and understanding of the diseases progress. In addition, increase in funding from government in life science research and development and advancements in molecular biology expected to boost the synthetic biology during the forecast period. Furthermore, private institutional contribution to synthetic biology research expected to push the market growth. However, lack of regulatory framework, biosafety and biosecurity issues coupled with government policies may hinder the synthetic biology market growth over the forecast period.


North America dominates the market share in

Synthetic Biology Market

Geographically, synthetic biology market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America and Europe expected to be a major markets for the synthetic biology owing to the factors such as increase in government funding for the synthetic biology research. According to Woodrow Wilson Center Report, synthetic biology research received about fund of $ 430 Mn in U.S. During 2005 to 2010 European governments contributed $160Mn fund for synthetic biologists. In addition, well-developed healthcare infrastructure and presence of major market players in both regions are expected to drive the market revenue growth. Asia Pacific region expected to grow at notable rate owing to the developing healthcare infrastructure, emergence of the Asia based biotechnological and synthetic biology firms and growing R&D investments in this region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In January 2017, Ginkgo Bioworks, a microorganism company acquired a provider of synthetic DNA Gen9. By this acquisition, company seeks to improve its speed and capacity in constructing new organism design for use across the multiple industries

Key

Key Features of the Report

Synthetic Biology Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Agilent Technologies (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • GEN9 Inc. (U.S.)
  • Novozymes
  • Amyris Biotechnologies (U.S.)
  • Merck KGaA (Germany)
  • Epoch Life Science Inc. (U.S.)
  • Intrexon Corporation (U.S.)
  • Gevo Inc. (U.S.)
  • Gingko Bioworks (U.S)
  • Twist Bioscience
  • GenScript
  • Integrated DNA Technologies, Inc.
  • Synthetic Genomics Inc.
  • New England Biolabs
  • Sangamo Therapeutics, Inc. (U.S.)

Description

The global synthetic biology market size is estimated to reach USD 9.32 billion at a CAGR of 26.5% from 2021 to 2027. Synthetic biology is a new interdisciplinary area of medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within the both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for development of artificial biological systems for research engineering and medical applications. The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market. For instance, in March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX